Plant Advanced Technologies SA (ALPAT.PA)
EUR 10.5
(0.0%)
EUR 10.5
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.68 Million EUR | -28.11% |
| 2022 | 2.33 Million EUR | 1.48% |
| 2021 | 2.3 Million EUR | 34.09% |
| 2020 | 1.71 Million EUR | 46.57% |
| 2019 | 1.17 Million EUR | 62534.41% |
| 2018 | 1872.47 EUR | 28.04% |
| 2017 | 1462.39 EUR | -7.27% |
| 2016 | 1577.12 EUR | -16.1% |
| 2015 | 1879.77 EUR | 11.63% |
| 2014 | 1684.00 EUR | -99.86% |
| 2013 | 1.2 Million EUR | 31.57% |
| 2012 | 917 Thousand EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 1.68 Million EUR | -28.11% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q4 | 1.44 Million EUR | 0.0% |
| 2022 FY | 2.33 Million EUR | 1.48% |
| 2022 Q2 | 896 Thousand EUR | 0.0% |
| 2021 Q4 | 1.32 Million EUR | 0.0% |
| 2021 FY | 2.3 Million EUR | 34.09% |
| 2021 Q2 | 980 Thousand EUR | 0.0% |
| 2020 Q4 | 941.13 Thousand EUR | 0.0% |
| 2020 FY | 1.71 Million EUR | 46.57% |
| 2020 Q2 | 314.96 Thousand EUR | 0.0% |
| 2019 FY | 1.17 Million EUR | 62534.41% |
| 2019 Q4 | 887.39 Thousand EUR | 0.0% |
| 2019 Q2 | 285.42 Thousand EUR | 0.0% |
| 2018 Q2 | 744.13 EUR | 0.0% |
| 2018 Q4 | 1128.34 EUR | 0.0% |
| 2018 FY | 1872.47 EUR | 28.04% |
| 2017 Q4 | 984.00 EUR | 0.0% |
| 2017 FY | 1462.39 EUR | -7.27% |
| 2017 Q2 | 478.39 EUR | 0.0% |
| 2016 Q2 | 345.11 EUR | 0.0% |
| 2016 FY | 1577.12 EUR | -16.1% |
| 2016 Q4 | 1232.01 EUR | 0.0% |
| 2015 FY | 1879.77 EUR | 11.63% |
| 2015 Q4 | 1175.48 EUR | 0.0% |
| 2015 Q2 | 704.29 EUR | 0.0% |
| 2014 FY | 1684.00 EUR | -99.86% |
| 2014 Q2 | 594.95 EUR | 0.0% |
| 2014 Q4 | 1089.04 EUR | 0.0% |
| 2013 Q1 | 301.62 Thousand EUR | 0.0% |
| 2013 Q3 | 301.62 Thousand EUR | 52012.49% |
| 2013 Q4 | 992.26 EUR | -99.67% |
| 2013 FY | 1.2 Million EUR | 31.57% |
| 2013 Q2 | 578.80 EUR | -99.81% |
| 2012 Q2 | 229.25 Thousand EUR | 0.0% |
| 2012 Q3 | 229.25 Thousand EUR | 0.0% |
| 2012 Q4 | 301.62 Thousand EUR | 31.57% |
| 2012 FY | 917 Thousand EUR | 0.0% |
| 2012 Q1 | 229.25 Thousand EUR | 0.0% |
| 2011 Q4 | 229.25 Thousand EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ABIONYX Pharma SA | 4.64 Million EUR | 63.76% |
| ABIVAX Société Anonyme | 4.62 Million EUR | 63.611% |
| Adocia SA | 2.15 Million EUR | 21.79% |
| Aelis Farma SA | 9.05 Million EUR | 81.428% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 3.15 Million EUR | 46.636% |
| genOway Société anonyme | 20.04 Million EUR | 91.612% |
| IntegraGen SA | 12.53 Million EUR | 86.588% |
| Medesis Pharma S.A. | 300.03 Thousand EUR | -460.441% |
| Neovacs S.A. | 533.41 Thousand EUR | -215.238% |
| NFL Biosciences SA | - EUR | -Infinity% |
| Quantum Genomics Société Anonyme | 19.79 Thousand EUR | -8394.216% |
| Sensorion SA | 4.74 Million EUR | 64.548% |
| Theranexus Société Anonyme | 296.33 Thousand EUR | -467.445% |
| TME Pharma N.V. | 17 Thousand EUR | -9791.265% |
| Valbiotis SA | 4.73 Million EUR | 64.473% |
| TheraVet SA | 1.07 Million EUR | -55.977% |
| Valerio Therapeutics Société anonyme | 1.8 Million EUR | 6.583% |
| DBV Technologies S.A. | - EUR | -Infinity% |
| Genfit S.A. | 28.56 Million EUR | 94.113% |
| GeNeuro SA | - EUR | -Infinity% |
| Innate Pharma S.A. | 51.9 Million EUR | 96.76% |
| Inventiva S.A. | 17.47 Million EUR | 90.379% |
| MaaT Pharma SA | 2.22 Million EUR | 24.528% |
| MedinCell S.A. | 9.16 Million EUR | 81.643% |
| Nanobiotix S.A. | 30.05 Million EUR | 94.406% |
| OSE Immunotherapeutics SA | 2.22 Million EUR | 24.494% |
| Poxel S.A. | 1.98 Million EUR | 15.118% |
| GenSight Biologics S.A. | 1.26 Million EUR | -32.716% |
| Transgene SA | 1.18 Million EUR | -42.02% |
| Valneva SE | 153.71 Million EUR | 98.906% |